Research packs
Incretin peptides: evidence review
A structured review of the published literature on GLP-1, GIP and glucagon receptor agonist peptides, from receptor pharmacology to registered clinical trials.
From £149
Richmont publishes research and market information only. We do not sell, supply or broker any peptide or compound. Read our scope
Evidence reviews, market reports and regulatory briefings for people who need to understand the peptide field properly. Every claim is referenced, every edition is dated, and no supplier pays to be included.
Richmont is a research publisher. Our packs help you understand a field: what has been studied, what the market looks like and how it is regulated. They are not a route to obtaining or using any substance.
Each pack is a self-contained PDF report with a reference library. Research packs review the published evidence; market packs cover suppliers, channels, pricing and regulation.
Research packs
A structured review of the published literature on GLP-1, GIP and glucagon receptor agonist peptides, from receptor pharmacology to registered clinical trials.
From £149
Market packs
New editionHow the research peptide market is structured: who supplies it, through which channels, at what prices, and how quality is (and isn't) evidenced.
From £349
Market packs
A plain-English briefing on how peptides are regulated in the UK: medicines classification, advertising rules, import, cosmetics and sport.
From £199
Every pack follows the same structure, so you always know where to find the method, the evidence and its limitations. This is the contents page from our market report.
Contents
UK and EU research peptide market report
Page numbers refer to the current edition.
Read the scope and contents of each pack. If you're not sure which one answers your question, ask us first.
Add packs to your basket, confirm you understand what you're buying, then pay by bank transfer.
Your download link arrives by email within minutes. Corrections to your edition are sent to you free of charge.
Our readers need an accurate, sourced picture of the field rather than marketing.
Every factual claim in a Richmont pack is referenced to its source. We grade the strength of evidence, say plainly where it is weak, and separate what studies found from what is merely claimed. Market figures come with their method and date, so you can judge them yourself.
No. Richmont sells research and market information only. We do not manufacture, sell, supply, source or broker any peptide or other substance, and we can't put you in touch with anyone who does.
No. Our packs contain no dosing, administration or usage guidance for people or animals. Where studies report doses, we describe the study design, not instructions.
No. Nothing we publish is medical advice. If you have a health question, speak to a GP, pharmacist or other registered healthcare professional.
Packs are researched and written by Richmont's analysts and reviewed before release. Each pack names its authors, reviewers and review date.
As soon as your payment is confirmed, your downloads appear on your order page and we email you the links. Links stay active for 30 days.
Because packs are digital and supplied immediately, the 14-day cancellation right ends once your download is made available, and you agree to this before paying. If a pack is faulty or not as described, you're entitled to a repair, replacement or refund. See our cancellations and refunds page for details.
Choose a team or company licence when you buy. A single-user licence covers one named person. For institutions or larger teams, contact us.
No. We don't accept payment, free products or commission from any supplier. Our market reports anonymise suppliers and explain how they were selected.
Questions about a pack, team licences, custom research or corrections. We reply within two working days.
Or email hello@richmont-consultants.co.uk